| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Development Center No. 3, Konica Corporation, No. 1 Sakura-Machi, Hino-Shi, Tokyo 191 [M. U., T. S., T. U.]; Department of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160 [S. N.]; and Institute of Life Science, Soka University, 1-236 Tangi-cho, Hachioji-Shi, Tokyo 192 [H. N.], Japan
Mouse monoclonal antibodies against human (ß14)galactosyl-transferase (GalT) purified from human ovarian tumor effusion fluids were prepared and characterized. GalT purified from normal human plasma showed a single diffused band in nondenaturing polyacrylamide gel electrophoresis, but GalT purified from human ovarian tumor effusion fluids showed several olgomeric bands and a monomeric band in nondenaturing polyacrylamide gel electrophoresis. These oligomeric bands were dissociated into monomer by urea treatment and polymerized by a 2-mercaptoethanol treatment. Nine monoclonal antibodies (MAb) were prepared by immunization of purified GalT from human ovarian tumor effusion fluids and classified into three groups. Type I MAbs (MAb8611, MAb8913, and MAb8919) reacted only to the GalT monomer. Type II MAbs (MAb4880, MAb8507, and MAb8628) reacted to both the GalT monomer and the GalT polymer. Type III MAbs (MAb7907, MAb8513, and MAb8677) reacted only to the GalT polymer. These MAbs except MAb7907 could recover GalT enzyme activity from effusion fluids by immunoprecipitation. A fraction passed through MAb8513 affinity chromatography still showed reactivity to MAb8919, demonstrating that an epitope of MAb8513 resides on a minor part of GalT. A sandwich immunoassay (MAb8513-MAb8628HRP) was developed, and serum samples from ovarian cancer patients and benign ovarian patients were tested. The levels of sandwich immunoassay of serum samples from cancer were elevated significantly compared to those from benign and did not necessarily correlate to total GalT enzyme activity in serum samples. These results suggested that MAb8513 (Type III) might recognize a unique GalT associated with tumor (GAT).
1 To whom requests for reprints should be addressed.
Received 6/ 8/92. Accepted 9/11/92.
This article has been cited by other articles:
![]() |
Y. Ikehara, T. Sato, T. Niwa, S. Nakamura, M. Gotoh, S. K. Ikehara, K. Kiyohara, C. Aoki, T. Iwai, H. Nakanishi, et al. Apical Golgi localization of N,N'-diacetyllactosediamine synthase, {beta}4GalNAc-T3, is responsible for LacdiNAc expression on gastric mucosa Glycobiology, September 1, 2006; 16(9): 777 - 785. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kamiyama, N. Sasaki, E. Goda, K. Ui-Tei, K. Saigo, H. Narimatsu, Y. Jigami, R. Kannagi, T. Irimura, and S. Nishihara Molecular Cloning and Characterization of a Novel 3'-Phosphoadenosine 5'-Phosphosulfate Transporter, PAPST2 J. Biol. Chem., April 21, 2006; 281(16): 10945 - 10953. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Suda, S. Kamiyama, M. Suzuki, N. Kikuchi, K.-i. Nakayama, H. Narimatsu, Y. Jigami, T. Aoki, and S. Nishihara Molecular Cloning and Characterization of a Human Multisubstrate Specific Nucleotide-sugar Transporter Homologous to Drosophila fringe connection J. Biol. Chem., June 18, 2004; 279(25): 26469 - 26474. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kamiyama, T. Suda, R. Ueda, M. Suzuki, R. Okubo, N. Kikuchi, Y. Chiba, S. Goto, H. Toyoda, K. Saigo, et al. Molecular Cloning and Identification of 3'-Phosphoadenosine 5'-Phosphosulfate Transporter J. Biol. Chem., July 3, 2003; 278(28): 25958 - 25963. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Q. Palacpac, S. Yoshida, H. Sakai, Y. Kimura, K. Fujiyama, T. Yoshida, and T. Seki Stable expression of human beta 1,4-galactosyltransferase in plant cells modifies N-linked glycosylation patterns PNAS, April 13, 1999; 96(8): 4692 - 4697. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nakamura, T. Kudo, H. Narimatsu, Y. Furukawa, J. Kikuchi, S. Asakura, W. Yang, S. Iwase, K. Hatake, and Y. Miura Single Glycosyltransferase, Core 2 beta 1right-arrow6-N-acetylglucosaminyltransferase, Regulates Cell Surface Sialyl-Lex Expression Level in Human Pre-B Lymphocytic Leukemia Cell Line KM3 Treated with Phorbolester J. Biol. Chem., October 9, 1998; 273(41): 26779 - 26789. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kain, K. Angata, D. Kerjaschki, and M. Fukuda Molecular Cloning and Expression of a Novel Human trans-Golgi Network Glycoprotein, TGN51, That Contains Multiple Tyrosine-containing Motifs J. Biol. Chem., January 9, 1998; 273(2): 981 - 988. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Skrincosky, R. Kain, A. El-Battari, M. Exner, D. Kerjaschki, and M. Fukuda Altered Golgi Localization of Core 2 beta -1,6-N-Acetylglucosaminyltransferase Leads to Decreased Synthesis of Branched O-Glycans J. Biol. Chem., September 5, 1997; 272(36): 22695 - 22702. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Schwientek, H. Narimatsu, and J. F. Ernst Golgi Localization and in Vivo Activity of a Mammalian Glycosyltransferase (Human beta1,4-Galactosyltransferase) in Yeast J. Biol. Chem., February 16, 1996; 271(7): 3398 - 3405. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Cho, J.-c. Yeh, M. Cho, and R. D. Cummings Transcriptional Regulation of alpha1,3-Galactosyltransferase in Embryonal Carcinoma Cells by Retinoic Acid J. Biol. Chem., February 9, 1996; 271(6): 3238 - 3246. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Yamaguchi and M. N. Fukuda Golgi Retention Mechanism of [IMAGE]-1,4-Galactosyltransferase J. Biol. Chem., May 19, 1995; 270(20): 12170 - 12176. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |